123 related articles for article (PubMed ID: 38389369)
21. Agreement Between Magnetic Resonance Imaging and Pathologic Findings in the Tumor Size Evaluation Before and After Neoadjuvant Chemotherapy Treatment: A Prospective Study.
Cheng J; Hou Y; Li J; Wang W; Xu Y; Yang C; Ma L; Dhillon HS; Openkova MS; Fan X; Li Z; Li K; Lou G
Int J Gynecol Cancer; 2017 Sep; 27(7):1472-1479. PubMed ID: 28644161
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer].
Wang YT; Li B; Li XG; Ma SK; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):588-594. PubMed ID: 31550774
[No Abstract] [Full Text] [Related]
23. Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer.
Pinkavova I; Fischerova D; Zikan M; Burgetova A; Slama J; Svarovsky J; Dundr P; Dusek L; Cibula D
Ultrasound Obstet Gynecol; 2013 Dec; 42(6):705-12. PubMed ID: 23495185
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
25. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
26. Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.
Feng Y; Liu H; Ding Y; Zhang Y; Liao C; Jin Y; Ai C
Tumori; 2020 Apr; 106(2):155-164. PubMed ID: 31736439
[TBL] [Abstract][Full Text] [Related]
27. Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study.
Zhao H; He Y; Zhu LR; Wang JL; Guo HY; Xu T; Wang YQ; Yao Y; Wu YM
Medicine (Baltimore); 2019 May; 98(21):e15604. PubMed ID: 31124937
[TBL] [Abstract][Full Text] [Related]
28. Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature.
Liu L; Deng X; Guo S; Yang S
Diagn Pathol; 2023 Sep; 18(1):107. PubMed ID: 37752528
[TBL] [Abstract][Full Text] [Related]
29. Pelvic bones ADC could help to predict severe hematologic toxicity in patients undergoing concurrent chemoradiotherapy for cervical cancer.
Pang H; Lai Q; Liu G; Song Q; Tong R; Chen Q; Luo Y; Yu T; Dong Y
Magn Reson Imaging; 2022 Dec; 94():98-104. PubMed ID: 35777686
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis.
Song Y; Liu Y; Lin M; Sheng B; Zhu X
Drug Des Devel Ther; 2019; 13():79-102. PubMed ID: 30587930
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy.
Kong TW; Lee EJ; Lee Y; Chang SJ; Son JH; Ryu HS
Obstet Gynecol Sci; 2014 Nov; 57(6):539-43. PubMed ID: 25469346
[TBL] [Abstract][Full Text] [Related]
34. FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.
Plante M; van Trommel N; Lheureux S; Oza AM; Wang L; Sikorska K; Ferguson SE; Han K; Amant F
Int J Gynecol Cancer; 2019 Jun; 29(5):969-975. PubMed ID: 31101688
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer.
Xiao J; Zhou J; Liang L; Liu F; Liang H; Xu C; Meng J
J BUON; 2019; 24(3):967-974. PubMed ID: 31424649
[TBL] [Abstract][Full Text] [Related]
36. A retrospective analysis of cisplatin/carboplatin plus paclitaxel in advanced or recurrent cervical cancer.
Song D; Kong W; Zhang T; Han C; Liu T; Jiao S; Chen J
J Obstet Gynaecol; 2019 Apr; 39(3):389-394. PubMed ID: 30663464
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study.
Ngabonziza E; Ghebre R; DeBoer RJ; Ntasumbumuyange D; Magriples U; George J; Grover S; Bazzett-Matabele L
BMC Womens Health; 2024 Mar; 24(1):204. PubMed ID: 38555423
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy with paclitaxel plus cisplatin before radical surgery for locally advanced cervical cancer during pregnancy: A case series and literature review.
Huang H; Quan Y; Qi X; Liu P
Medicine (Baltimore); 2021 Aug; 100(32):e26845. PubMed ID: 34397891
[TBL] [Abstract][Full Text] [Related]
39. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer.
Yang L; Guo J; Shen Y; Cai J; Xiong Z; Dong W; Min J; Wang Z
Int J Clin Exp Med; 2015; 8(8):13690-8. PubMed ID: 26550314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
